Cargando…

Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation

Detalles Bibliográficos
Autores principales:	Martino, Rodrigo, García-Cadenas, Irene, Esquirol, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552208/ https://www.ncbi.nlm.nih.gov/pubmed/34711914 http://dx.doi.org/10.1038/s41409-021-01507-3

Ejemplares similares

Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
por: Asawapanumas, Thiti, et al.
Publicado: (2022)

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia
por: Gangat, Naseema, et al.
Publicado: (2022)

Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease
por: Dovern, E., et al.
Publicado: (2023)

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Sung-Hoon, et al.
Publicado: (2012)

Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation
por: Zhu, Panpan, et al.
Publicado: (2022)

ABO isohemagglutinin titration or hemolysin test: what should we do to reduce the risk of passive hemolysis?()
por: Castilho, Lilian
Publicado: (2015)

Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Handisurya, Ammon, et al.
Publicado: (2020)

Myelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
por: Kim, Hyoung Doo, et al.
Publicado: (2004)

Pure red cell aplasia and associated thymoma
por: Rosu, Cristian, et al.
Publicado: (2011)

Lenalidomide-Induced Pure Red Cell Aplasia
por: Dolai, Tuphan Kanti, et al.
Publicado: (2014)

Emtricitabine-induced pure red cell aplasia
por: Manickchund, Nithendra, et al.
Publicado: (2019)

Erythropoietin‐induced pure red cell aplasia
por: Yeung, Vivian K. P.
Publicado: (2022)

Pure Red Cell Aplasia Associated With Thymoma
por: Thangatorai, Ramesh
Publicado: (2023)

TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib
por: Poudyal, Bishesh Sharma, et al.
Publicado: (2016)

Pure Red Blood Cell Aplasia and Isoniazid Use
por: Loulergue, Pierre, et al.
Publicado: (2007)

Zidovudine-induced reversible pure red cell aplasia
por: Balakrishnan, Anuja, et al.
Publicado: (2010)

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia
por: Briones, Juan, et al.
Publicado: (2013)

Rational management approach to pure red cell aplasia
por: Balasubramanian, Suresh Kumar, et al.
Publicado: (2018)

Pure red cell aplasia induced by epoetin zeta
por: Panichi, Vincenzo, et al.
Publicado: (2016)

Pure Red Cell Aplasia Associated with Good Syndrome
por: Okui, Masayuki, et al.
Publicado: (2017)

Isoniazid Induced Pure Red Blood Cell Aplasia
por: Azhar, Waqas, et al.
Publicado: (2020)

Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021)

Clonal hematopoiesis in adult pure red cell aplasia
por: Fujishima, Naohito, et al.
Publicado: (2021)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
por: Ibrahim, Uroosa, et al.
Publicado: (2023)

Acquired pure red cell aplasia: updated review of treatment
por: Sawada, Kenichi, et al.
Publicado: (2008)

Pure Red Cell Aplasia and Lymphoproliferative Disorders: An Infrequent Association
por: Vlachaki, Efthymia, et al.
Publicado: (2012)

Pure Red Cell Aplasia Caused by Acute Hepatitis A
por: Lee, Tae Heon, et al.
Publicado: (2011)

Pure Red Cell Aplasia Following Interleukin-2 Therapy
por: Dutcher, Janice P., et al.
Publicado: (2016)

Pure Red Cell Aplasia with Adult Onset Still's Disease
por: Robillard, Nicholas, et al.
Publicado: (2013)

Invasive Thymoma with Pure Red Cell Aplasia and Amegakaryocytic Thrombocytopenia
por: Onuki, Takuya, et al.
Publicado: (2016)

Acquired Amegakaryocytic Thrombocytopenia and Pure Red Cell Aplasia in Thymoma
por: Dahal, Sumit, et al.
Publicado: (2018)

Aggressive Systemic Mastocytosis in Association with Pure Red Cell Aplasia
por: Karam, Dhauna, et al.
Publicado: (2018)

The proliferative capacity of pure red cell aplasia bone marrow cells.
por: Katz, L. J., et al.
Publicado: (1981)

Pure red cell aplasia due to azathioprine therapy for Crohn's disease
por: Kamath, Nagesh, et al.
Publicado: (2016)

Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide
por: Ito, Tomoki, et al.
Publicado: (2018)

Pure red cell aplasia and seronegative myasthenia gravis in association with thymoma
por: Lee, Sun Yong, et al.
Publicado: (2020)

Pure red cell aplasia and amegakaryocytic thrombocytopenia in thymoma: The uncharted territory
por: Dragani, Matteo, et al.
Publicado: (2020)

A case series of emtricitabine-induced pure red cell aplasia
por: Manickchund, Nithendra, et al.
Publicado: (2021)

Linezolid-Induced Pure Red Cell Aplasia: A Case Report
por: Yang, Xiao-Yan, et al.
Publicado: (2022)

A pregnant woman with thymoma-associated pure red cell aplasia
por: Shibata, Megumi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ckdo9ll4jsvbjn581828b74nst